TY - JOUR
AU - Christopher M. Jones
AU - Carla Shoff
AU - Carlos Blanco
AU - Jan L. Losby
AU - Shari M. Ling
AU - Wilson M. Compton
A1 - 
AD - National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, US fjr0@cdc.gov; Office of the Administrator, Centers for Medicare & Medicaid Services, Baltimore, MD, US ; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, US ; Centers for Clinical Standards and Quality, Centers for Medicare & Medicaid Services, Baltimore, MD, US ; Jones, Christopher M.,4770 Buford Hwy NE,Atlanta,US,30341,National Center for Injury Prevention and Control, Centers for Disease Control and Prevention,fjr0@cdc.gov
BT - JAMA Psychiatry
C5 - Opioids & Substance Use; HIT & Telehealth ; Healthcare Disparities
CP - 5
DB - APA PsycInfo®
DO - 10.1001/jamapsychiatry.2023.0310
IS - 5
JF - JAMA Psychiatry
LA - English
PY - 2023
SN - 2168-622X, 2168-622X
SP - 508
EP - 514+
ST - Association of receipt of opioid use disorder–related telehealth services and medications for opioid use disorder with fatal drug overdoses among medicare beneficiaries before and during the COVID-19 pandemic
T1 - Association of receipt of opioid use disorder–related telehealth services and medications for opioid use disorder with fatal drug overdoses among medicare beneficiaries before and during the COVID-19 pandemic
T2 - JAMA Psychiatry
TI - Association of receipt of opioid use disorder–related telehealth services and medications for opioid use disorder with fatal drug overdoses among medicare beneficiaries before and during the COVID-19 pandemic
U1 - Opioids & Substance Use; HIT & Telehealth ; Healthcare Disparities
U3 - 10.1001/jamapsychiatry.2023.0310
VL - 80
VO - 2168-622X, 2168-622X
Y1 - 2023
ER -